Sales rise 8.63% to Rs 353.34 crore
Net profit of ERIS Lifesciences rose 9.91% to Rs 118.39 crore in the quarter ended September 2021 as against Rs 107.72 crore during the previous quarter ended September 2020. Sales rose 8.63% to Rs 353.34 crore in the quarter ended September 2021 as against Rs 325.27 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales353.34325.27 9 OPM %39.5738.36 -PBDT145.74126.40 15 PBT130.78115.84 13 NP118.39107.72 10Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
